8-K ·Filed Sep 15, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
Monitor the next 10-Q or subsequent 8-K for any financial impact from the director/officer change or shareholder vote. No immediate read-through on fundamentals.
Latest settled — T+20d
RKDA ▼ -51.86% at T+20d
NEUTRAL call -51.86% · α vs SPY -54.83% · entry $0.4310 → $0.2075
Latest observation: T+28 -47.15% FF3 residual α
T+1d
+2.65%
call +2.65% · α +2.32%
$0.4424
settled 6w ago
T+5d
+5.34%
call +5.34% · α +4.52%
$0.4540
settled 5w ago
T+20d
-51.86%
call -51.86% · α -54.83%
$0.2075
settled 14d ago
T+60d
Pending
in 6w
Price Chart
Loading chart...
Executive Summary
Arcadia Biosciences filed an 8-K covering Item 5.02 (director/officer changes), Item 5.07 (shareholder vote results), and Item 9.01 (exhibits). The filing is administrative in nature with no financial results, guidance, or material operational events disclosed.
Key Facts
- 8-K filed with Items 5.02, 5.07, and 9.01
- Item 5.02 covers departure or appointment of directors/officers
- Item 5.07 covers shareholder vote submission
- Item 9.01 covers financial statements and exhibits
- No financial figures, guidance, or material operational data provided in the filing
Financial Impact
No dollar amounts or percentages disclosed in the filing
Risk Factors
- Potential leadership transition uncertainty if no successor named
- No financial data to assess operational impact
Market Snapshot
Exchange
Nasdaq
Sector
Crude Petroleum & Natural Gas
Analyst Consensus
86% bullish (7 analysts)
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-391780 |
| Document: 0001193125-26-391780-index.html | 0001193125-26-391780 |
| Document: 0001193125-26-391780.txt | 0001193125-26-391780 |
12 reports for RKDA
100% Hit rate @ T+60 Went positive at some point 7 of 7 best @ T+60▲ +57.34%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 26d ago | SC 13G | $0.2800 | awaiting T+60 | — | $0.1620 (−42.14%) |
Sep 15, 2026 5w ago | 8-K | $0.4310 | awaiting T+60 | — | $0.1620 (−62.41%) |
Jul 9, 2026 15w ago | EFFECT | $0.6755 $0.2882 | ▲ +57.34% | ▲ +58.97% | $0.1620 (+76.02%) |
Jul 2, 2026 16w ago | 8-K | $0.7330 $0.3080 | ▼ −57.98% | ▼ −61.55% | $0.1620 (−77.90%) |
Jun 26, 2026 17w ago | S-3 | $0.7190 $0.4480 | ▲ +37.69% | ▲ +42.08% | $0.1620 (+77.47%) |
Jun 15, 2026 19w ago | 8-K | $0.9183 $0.4797 | ▲ +47.76% | ▲ +48.77% | $0.1620 (+82.36%) |
Jun 12, 2026 19w ago | Press Release | $0.9183 $0.4797 | ▲ +47.76% | ▲ +48.77% | $0.1620 (+82.36%) |
Jun 12, 2026 19w ago | Press Release | $0.9180 $0.4530 | ▲ +50.65% | ▲ +51.31% | $0.1620 (+82.35%) |
May 14, 2026 23w ago | 8-K | $0.9560 $0.6699 | ▲ +29.93% | ▲ +34.44% | $0.1620 (+83.05%) |
Apr 30, 2026 25w ago | 10-K/A | $1.12 $0.6300 | ▼ −43.75% | ▼ −46.82% | $0.1620 (−85.54%) |
Showing 10 of 12
US Market Status
Market Closed — Opens Wed (13h 22m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers